Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
Antibiotics not helpful for cough due to lower respiratory tract infection
Apr 25, 2024
Despite patient beliefs, no effect was seen on the severity or duration of the cough.
COVID-19 meds like Paxlovid will soon have big price tags
Oct 30, 2023
The pills still will be available at no cost until those bought earlier by the federal government run out.
Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.
Use of acid-suppression therapy linked to migraine, severe headache
Apr 26, 2024
Adjusted odds ratios of 1.70, 1.40 and 1.30 were seen for proton pump inhibitors, H2 receptor antagonists and generic antacids, respectively.
Four in 10 US adults say they know someone who died from drug overdose
Feb 28, 2024
One-third of those say their lives were disrupted by the overdose death.
Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.
Early antibiotics for COVID-19 can cut recovery time
Mar 25, 2024
The authors say the findings show a role for microbiome and the development of long COVID symptoms.
FDA approves Rezdiffra for nonalcoholic steatohepatitis
Mar 15, 2024
Drug was approved on an ‘accelerated’ schedule due to pressing medical need
FDA approves Aurlumyn for severe frostbite
Feb 15, 2024
The newly approved medication lowers the need for amputation of fingers or toes.